ISSN: 2574-7797
Authors: Darshan SS*, Rutika BW, Piyush VB, Khemchand RS, Chandrashekhar DP and Dhananajay MP
A calcium channel blocker called lercanidipine shows promise as a treatment for hypertension, especially in older people. Exhibiting greater effectiveness in comparison to other calcium channel blockers, it presents encouraging opportunities for the management of hypertension. Its use has a low risk to renal function, which sets it apart from other medicines in its class that might have a negative impact on the kidneys. Consequently, lercanidipine distinguishes itself as a beneficial and well-tolerated treatment choice for hypertension patients, providing a possible way to address cardiovascular issues without jeopardizing renal function, particularly in the elderly population.
Keywords: Lercanidipine; Hypertension; Calcium channel blocker; Renal Protection
